Clinical Trial Update: A Study of DM002 in Patients With Advanced Solid Tumors [Phase 1]

View source ↗

Summary

Phase 1 clinical trial for DM002 in patients with advanced solid tumors is recruiting, including ovarian cancer, prostate cancer, endometrial cancer, colorectal…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Colorectal Cancer
• Endometrial Cancer
• Ovarian Cancer
• Prostate Cancer
• Solid Tumors

Drugs mentioned

• DM002 (DM002)

Snippet

Sponsor: Xadcera Biopharmaceutical (Suzhou) Co., Ltd. | Conditions: Ovarian Neoplasms, Prostatic Neoplasms | Phase 1 | Status: RECRUITING